Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital, Aalborg, Denmark.
Eur Neuropsychopharmacol. 2012 Oct;22(10):747-50. doi: 10.1016/j.euroneuro.2012.02.008. Epub 2012 Mar 21.
Drug attitude inventory (DAI-30) is considered to be the best predictor of poor adherence in first-episode schizophrenia. We compared the short version (DAI-10) with DAI-30 in long-term schizophrenia, documented if DAI was associated with poor insight, PANSS and GAF and constructed DAI-10 percentiles. DAI-30 and DAI-10 were homogenous (r = 0.82 and 0.72, respectively) with good test-retest reliability (0.79). The correlation between the DAI versions was high (0.94). Percentile scores of DAI-10 were computed. DAI is an easy-to-use self-report instrument seemingly assessing a unique clinical dimension relevant to non-adherence. DAI-10 might be preferred for its simplicity and good psychometric properties.
药物态度量表（DAI-30）被认为是预测首发精神分裂症患者服药依从性差的最佳指标。我们比较了长期精神分裂症患者的短版（DAI-10）和 DAI-30，观察 DAI 是否与洞察力差、PANSS 和 GAF 有关，并构建了 DAI-10 百分位数。DAI-30 和 DAI-10 具有同质性（r 分别为 0.82 和 0.72），且具有良好的重测信度（0.79）。两个版本之间的相关性很高（0.94）。计算了 DAI-10 的百分位数分数。DAI 是一种易于使用的自评工具，似乎评估了与不依从相关的独特临床维度。DAI-10 可能因其简单性和良好的心理测量特性而更受青睐。
